Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FoxWayne Enterprises Acquisition Corp.FOXW · Entity 143677 | Director | January 19, 2021 | January 19, 2021 |
| Rocket One Inc.RKTO · Entity 7736 | Director | May 26, 2026 | May 28, 2026 |
| Silo Pharma, Inc.SILO · Entity 8320 | Director | May 23, 2025 | May 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FoxWayne Enterprises Acquisition Corp.
Report date January 19, 2021 · Filed January 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-19 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to adjustment. The Class B Common Stock has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to adjustment. The Class B Common Stock has no expiration date.
Rocket One Inc.
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2036-05-26 | Direct | 75,000 |
Reported balance
After 2026-05-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 75,000 · Balance 75,000 F1: The options were issued pursuant to the Rocket One Inc. Amended and Restated 2022 Omnibus Equity Incentive Plan, as amended, and vested in full upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options were issued pursuant to the Rocket One Inc. Amended and Restated 2022 Omnibus Equity Incentive Plan, as amended, and vested in full upon grant.
Silo Pharma, Inc.
Report date May 23, 2025 · Filed May 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.43 · Expires 2035-05-23 | Direct | 50,000 |
Reported balance
After 2025-05-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-05-23 · Grant · Acquired 50,000 · Balance 50,000 F1: The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed May 28, 2026 20:15 UTC | Rocket One Inc. RKTO · Entity 7736 | GrantOptions · Derivative | 75,000 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001213900-26-062128 · ownership.xml · derivative · entry 1 Pavell Jeff · CIK 0001840601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2036-05-26 F1 · kind: The options were issued pursuant to the Rocket One Inc. Amended and Restated 2022 Omnibus Equity Incentive Plan, as amended, and vested in full upon grant. Read SEC document |
| May 23, 2025 Filed May 27, 2025 23:00 UTC | Silo Pharma, Inc. SILO · Entity 8320 | GrantOptions (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001213900-25-047910 · ownership.xml · derivative · entry 1 Pavell Jeff · CIK 0001840601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-23 F1 · kind: The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 20:15 UTC | Rocket One Inc. HOTH · Entity 7736 | GrantOptions · Derivative | 25,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001213900-24-071462 · ownership.xml · derivative · entry 1 Pavell Jeff · CIK 0001840601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-08-19 F1 · kind: The options were issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 22:01 UTC | Rocket One Inc. HOTH · Entity 7736 | GrantOptions · Derivative | 25,000 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001213900-24-001958 · ownership.xml · derivative · entry 1 Pavell Jeff · CIK 0001840601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-05 F1 · kind: The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 20:15 UTC | Rocket One Inc. HOTH · Entity 7736 | GrantOptions · Derivative | 7,500 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001213900-23-057859 · ownership.xml · derivative · entry 1 Pavell Jeff · CIK 0001840601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2033-07-17 F1 · kind: The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant. Read SEC document |
| December 13, 2022 Filed Dec 13, 2022 21:40 UTC | Rocket One Inc. HOTH · Entity 7736 | GrantCommon Stock | 5,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-079538 · ownership.xml · nonDerivative · entry 1 Pavell Jeff · CIK 0001840601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,075 F1 · price: Issued for services as a member of the Issuer's Board of Directors. F2 · balance_after: The common stock was issued pursuant to the Issuer's 2018 Equity Incentive Plan and shall vest in three equal annual installments, with the first installment vesting on the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.